Maryland researchers receive $3.9M from NIH to develop new HIV treatment - Baltimore


Nov. 21, 2018 1:27 pm

Maryland researchers receive $3.9M from NIH to develop new HIV treatment

The work at the University of Maryland aims to contribute to treatments that could lead to "HIV remission and possible eradication."

Taking a closer look at Maryland's life sciences and medtech startups.

(Photo via

A team of Maryland researchers is leading an effort to develop a new HIV treatment that harnesses the body’s immune system to fight disease.

Yuxing Li, who is a professor at the Baltimore-based University of Maryland School of Medicine and a fellow at the University of Maryland’s Rockville-based Institute for Bioscience and Biotechnology Research, is leading the effort.

The National Institutes of Health recently awarded a $3.9 million grant to develop the immunotherapy treatment for HIV-1, which is one of the most common viruses that causes AIDS.

“The overall outcome of this study will advance our basic understanding of protective immunity against persistent virus infection and contribute to the development of safe and effective strategies for HIV remission and possible eradication,” Li said in a statement.

Li will work with IBBR researchers, Dr. Qingsheng Li of the University of Nebraska-Lincoln and Dr. Keith Reeves of Harvard Medical School and Beth Israel Deaconess Medical Center.

According to IBBR, the new treatment aims to block infection, and clear HIV-infected cells from the body in a way that currently available drugs known as antiretroviral treatments can’t do alone.

Previously, Dr. Yuxing Li’s team created antibodies that neutralized 95 percent of HIV-1 viruses. The upcoming work will “further optimize” the antibodies to recognize specific proteins and signal other parts of the immune system to assist in ridding the body of the cells that contain hard-to-reach “reservoirs” of the virus, according to the research team.

IBBR tabbed the work as having the potential to be commercialized and lead to new therapeutics.

Prior to NIH, the project received funding from MPowering the State, which supports work across University of Maryland, College Park and the University of Maryland, Baltimore. TEDCO’s MII program also supported proof-of-concept work.

Already a member? Sign in here
Connect with companies from the community
New call-to-action


BlueRidge.AI raises $1.9M to bring machine learning to factory floors

With new Baltimore space and $5M Series A, Whitebox grows ecommerce tech platform

Minnowtech receives $225K grant to bring imaging platform to shrimp farmers



How law firm Nemphos Braue is guiding startups along the new business learning curve

Baltimore, MD 21201

14 West

Junior Database Administrator

Apply Now
Baltimore, MD


Account Executive (Baltimore)

Apply Now


Vice President of Business Development

Apply Now

Ion Storage Systems raises $8M for solid state battery development

A trio of Baltimore institutions are forming partnerships with Baxter International

SeaPerch Challenge 2019 brought students’ underwater robots to the University of Maryland



Building a data acquisition system? Don’t make this mistake


emocha Mobile Health

Software Engineer

Apply Now

RackTop Systems

API Guru

Apply Now


Front End Developer

Apply Now

Sign-up for daily news updates from Baltimore

Do NOT follow this link or you will be banned from the site!